BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9174606)

  • 1. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
    Braud V; Jones EY; McMichael A
    Eur J Immunol; 1997 May; 27(5):1164-9. PubMed ID: 9174606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production, crystallization, and preliminary X-ray analysis of the human MHC class Ib molecule HLA-E.
    O'Callaghan CA; Tormo J; Willcox BE; Blundell CD; Jakobsen BK; Stuart DI; McMichael AJ; Bell JI; Jones EY
    Protein Sci; 1998 May; 7(5):1264-6. PubMed ID: 9605335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative peptide binding motifs of Qa-2 class Ib molecules define rules for binding of self and nonself peptides.
    Tabaczewski P; Chiang E; Henson M; Stroynowski I
    J Immunol; 1997 Sep; 159(6):2771-81. PubMed ID: 9300698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
    Buzyn A; Ostankovitch M; Zerbib A; Kemula M; Connan F; Varet B; Guillet JG; Choppin J
    Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.
    Ulbrecht M; Modrow S; Srivastava R; Peterson PA; Weiss EH
    J Immunol; 1998 May; 160(9):4375-85. PubMed ID: 9574542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qa-1b binds conserved class I leader peptides derived from several mammalian species.
    Kurepa Z; Hasemann CA; Forman J
    J Exp Med; 1998 Sep; 188(5):973-8. PubMed ID: 9730898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: requirement of class I signal sequence-derived peptides for HLA-E recognition by a mouse cytotoxic T cell clone.
    Martinozzi S; Pacasova R; Boulouis HJ; Ulbrecht M; Weiss EH; Sigaux F; Pla M
    J Immunol; 1999 May; 162(10):5662-5. PubMed ID: 10229795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.
    Cotterill LA; Stauss HJ; Millrain MM; Pappin DJ; Rahman D; Canas B; Chandler P; Stackpoole A; Simpson E; Robinson PJ; Dyson PJ
    Eur J Immunol; 1997 Sep; 27(9):2123-32. PubMed ID: 9341749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues.
    Rovero P; Viganò S; Pegoraro S; Revoltella R; Riganelli D; Fruci D; Greco G; Butler RH; Tanigaki N
    J Pept Sci; 1995; 1(4):266-73. PubMed ID: 9223004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
    Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
    Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.
    Nelson CA; Viner NJ; Young SP; Petzold SJ; Unanue ER
    J Immunol; 1996 Jul; 157(2):755-62. PubMed ID: 8752926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
    Braud VM; Allan DS; Wilson D; McMichael AJ
    Curr Biol; 1998 Jan; 8(1):1-10. PubMed ID: 9427624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.